Michael Retchin has announced the launch of a new company aimed at leveraging internet-scale datasets to develop new drugs. Despite the vast amount of data generated daily, only a small fraction is currently used in drug development. Retchin, who has years of experience building and investing in therapeutics companies, believes this new venture will address this inefficiency. The initiative comes amidst a broader trend of companies like Isomorphic Labs, EvolutionaryScale, DiffuseBio, Xaira Therapeutics, Recursion, and Inceptive using AI and foundation models to solve biological problems, particularly in drug discovery. However, a significant challenge for these startups remains access to data, with founders often needing to negotiate with big pharma for data access.
I couldn't be more excited for Michael's next adventure after his PhD. https://t.co/M28neFP0V3
Soon “we called with 100s KOLs” will be replaced with 1 query. Excited to exist at a time when I can directly benefit from it + even more excited to see my friend @MichaelRetchin working on it. He is hiring too (a lot of qs from software engineers on how to help bio - this is… https://t.co/zMdlhR54uU
Building scientific intelligence to cure diseases. Michael is just getting started here! 🚀 https://t.co/CQQwSIn3OD
Super excited to see what @MichaelRetchin will build - he's just getting started 🚀🚀 https://t.co/Vpo66oWyoy
over the last year I met several AI therapeutic companies, creating models for more efficient drug research. The number one issue these startups face is access to data. Founders spend most of their energy coalescing big pharma for access. hope there’s enough incentives here https://t.co/seAlp2CQOT
Confident that whatever Michael builds will be ultra useful to us - the people developing new drugs and finding ways to deliver them to patients. Congrats on the new endeavor! https://t.co/ffP3g4Fgs4
I’m starting a company. An internet-scale dataset is created every day that can be used to cure diseases. ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ Yet decisions for developing new drugs use a tiny fraction of it. ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ After years of building and investing in therapeutics… https://t.co/5u5ZHFIG4A
I’m starting a company. An internet-scale dataset is created every day that can be used to cure diseases. Yet decisions for making new drugs use a tiny fraction of it. After years of building and investing in therapeutics companies, I'm convinced that this is about to…
I’m starting a company. An internet-scale dataset is created every day that can be used to cure diseases. Yet decisions for making new drugs use a tiny fraction of it. After years of building and investing in therapeutics companies, I'm… https://t.co/4XHtrPHxny
I am seeing a lot of companies that want to solve biology with AI and foundation models. Some examples include: Isomorphic Labs, EvolutionaryScale, DiffuseBio, Xaira Therapeutics, Recursion, Inceptive, etc. But I feel like I don't see as many companies trying to solve healthcare…
I am seeing a lot of companies that want to solve biology with AI and foundation models. Some examples include: Isomorphic Labs, EvolutionaryScale, DiffuseBio, Xaira Therapeutics, Recursion, Inceptive, etc. (most of these companies are focused on drug discovery) But I feel like…